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Abstract
Background:  Metabolomics, or metabonomics, refers to the quantitative analysis of all
metabolites present within a biological sample and is generally carried out using NMR spectroscopy
or Mass Spectrometry. Such analysis produces a set of peaks, or features, indicative of the metabolic
composition of the sample and may be used as a basis for sample classification. Feature selection
may be employed to improve classification accuracy or aid model explanation by establishing a
subset of class discriminating features. Factors such as experimental noise, choice of technique and
threshold selection may adversely affect the set of selected features retrieved. Furthermore, the
high dimensionality and multi-collinearity inherent within metabolomics data may exacerbate
discrepancies between the set of features retrieved and those required to provide a complete
explanation of metabolite signatures. Given these issues, the latter in particular, we present the
MetaFIND application for 'post-feature selection' correlation analysis of metabolomics data.
Results: In our evaluation we show how MetaFIND may be used to elucidate metabolite signatures
from the set of features selected by diverse techniques over two metabolomics datasets.
Importantly, we also show how MetaFIND may augment standard feature selection and aid the
discovery of additional significant features, including those which represent novel class
discriminating metabolites. MetaFIND also supports the discovery of higher level metabolite
correlations.
Conclusion: Standard feature selection techniques may fail to capture the full set of relevant
features in the case of high dimensional, multi-collinear metabolomics data. We show that the
MetaFIND 'post-feature selection' analysis tool may aid metabolite signature elucidation, feature
discovery and inference of metabolic correlations.
Background
Metabolites are the small molecular intermediates and
products of an organism's metabolism. The set of metab-
olites present within an organism form its 'metabolome'
[1]. The comprehensive and quantitative analysis of the
whole metabolome is referred to as 'metabolomics' (or
metabonomics) [2]. The most commonly used experi-
mental techniques for measuring the global metabolome
are Nuclear Magnetic Resonance Spectroscopy (NMR)
and Mass Spectrometry (MS). Both experimental methods
produce spectral profiles which can be indicative of the
metabolic composition of experimental samples. After
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various pre-processing steps, a set of 'binned' spectral
regions (or peaks) is produced for each sample [3]. These
spectral regions or peaks may be viewed as a set of 'fea-
tures' that may be used to characterize and discriminate
between sample classes i.e. disease states, drug effects and
cell types.
Using the set of features produced by the above tech-
niques, several forms of data analysis may be performed
depending on the aim of an investigation [4,5]. If sample
class labels are unavailable, or in cases where the presence
of novel classes is suspected, 'unsupervised' classification
may be used to discover sample groupings. Data transfor-
mation methods such as Principal Component Analysis
(PCA) may be sufficient to reveal class structure within the
samples [6]. Hierarchical and partitional cluster analysis
may also be applied to model sample relationships,
within either the transformed or original feature space
[7,8]. When class labels are available they may be used to
support 'supervised' classification. Predictive models or
'classifiers' may then be built to classify unlabelled data.
Linear Discriminant Analysis (LDA) has been applied to
build a classification model from metabolomics data [9].
However due to the multi-collinear nature of metabo-
lomics data it is better practice to perform Principal Com-
ponent Analysis (PCA) prior to the application of LDA
(PCA-LDA) [10]. Discriminant Analysis based upon Par-
tial Least Squares (PLS-DA) has also become popular
within the metabolomics domain [11]. PLS-DA uncovers
the latent variables within the data that both model the
feature values and separate the sample classes. Recently
this technique has been enhanced in the form of Orthog-
onal-PLS-DA (O-PLS-DA) [12,13]. Other supervised
methods used in this domain include Support Vector
Machines (SVMs) and Artificial Neural Networks (ANN)
[14-16].
A topic that overlaps somewhat with supervised classifica-
tion is that of supervised feature selection. Feature selec-
tion may be employed to improve a classification model,
in terms of generalization performance and accuracy, by
eliminating non-informative features. Aside from this,
feature selection may also be used to gain further insight
into the rationale underlying class divisions within a par-
ticular domain. In the context of metabolomics, retrieving
the set of class discriminating features may aid in the iden-
tification of the class determining metabolites. This may
allow further elucidation of the system (e.g. disease mech-
anism) under investigation.
However, features selected on the basis of classification
accuracy, i.e. features that are sufficient to separate classes,
may not always translate directly into an explanation that
makes sense from the perspective of the bio-analytical sci-
entist. This is often the case in NMR metabolomics data,
where a metabolite may be represented by one or more
spectral features. In this case a subset of these features
(part of the metabolite signature) may provide a perfect
classification model. For example, the peaks 3.97 ppm,
7.55 ppm, 7.57 ppm and 7.85 ppm, which represent hip-
purate, can be seen in Figure 1. As these peaks belong to
the same metabolite they will vary together, or correlate,
over a set of samples. From the perspective of sample clas-
sification such correlated peaks may provide redundant
information. As a result, employing standard feature
selection alone may risk omitting features that are impor-
tant for metabolite signature identification. High dimen-
sional NMR metabolomics data is replete with feature
correlations (multi-collinearity) both within the signal
(features relevant to class explanation) and noise (irrele-
vant features).
Feature selection methods less prone to the bias effects of
multi-collinear data include those based on variable influ-
ence on the projection (VIP) values, derived from PLS-DA,
and  variable importance produced by a Random Forest
ensemble classifier. Interestingly, there is a fundamental
difference between Random Forest and PLS-DA. Unlike
PLS-DA, Random Forest is a non-parametric technique
and is unaffected by feature scale. For this reason, these
techniques may be seen to be somewhat complementary.
In both techniques other factors, such as noise within the
dataset or threshold selection, may cause relevant features
to be omitted from a selected set. As a result, some features
important for classification explanation and metabolite
signature identification may be not be retrieved.
To further aid the retrieval of all peaks and metabolites
relevant to both class discrimination and subsequent
explanation, a novel metabolomics feature analysis tool
called MetaFIND (Metabolomics Feature IN terrogation
and Discovery) has been developed. The MetaFIND appli-
cation addresses the multi-collinear aspect of metabo-
lomics data by providing an adjunct to standard feature
selection techniques. This takes the form of a 'post-feature
selection' correlation analysis step, as illustrated in Figure
2.
The initial function of MetaFIND is to analyse the set of
features retrieved by the investigator's chosen feature
selection technique and provide support, via an interac-
tive graphical interface, for uncovering the various metab-
olite signatures that may be present within this set. This
provides a tool to bridge the gap between data driven class
discrimination and domain explanation.
Secondly, MetaFIND also enables the user to examine cor-
relations outside the selected feature set i.e. between the
selected features and of the rest of the features in the data-
set. This has the potential to discover novel features over-BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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looked by the initial feature selection process. Any
additional features retrieved may then further aid identifi-
cation or discovery of metabolites. Lastly, MetaFIND
allows the higher level correlations between metabolite
signatures themselves to be examined. Both positively and
negatively correlated metabolites signature may be uncov-
ered. As discussed in [17], the identification of correlated
metabolites may in turn contribute to the construction of
the metabolic networks. Although some tools exist that
enable analysis of spectral correlations [18,19], MetaFIND
allows the user to dynamically examine the correlations of
individual spectral features retrieved by arbitrary feature
selection methods.
Feature selection
In this study MetaFIND was applied, in conjunction with
two alternative feature selection approaches, to investigate
two metabolomics datasets. The first feature selection
technique employed is referred to as Partial Least Squares
(or lately Projection to Latent Structures) Discriminant
Analysis (PLS-DA) and is one of the most commonly used
techniques within metabolomics and chemometrics in
general. In this study we also utilize a non-parametric fea-
ture selection method based on Random Forest classifica-
tion. We now provide a brief discussion of both PLS-DA
and Random Forest based feature selection strategies.
Partial Least Squares Discriminant Analysis
PLS Discriminant Analysis (PLS-DA) is a feature selection
technique based upon the Partial Least Squares regression
method for constructing predictive models developed by
Herman Wold [20]. PLS is an improvement on the use of
Multiple Linear Regression (MLR) in this context due to its
ability to handle data in which features far out-number
samples and in which many features are correlated (multi-
collinearity). In PLS-DA the response variable is produced
by encoding class labels as a binary vector of 1's and 0's
indicating class membership. PLS extracts the set of latent
variables which model the data but which are also corre-
The NMR spectrum of a urine sample Figure 1
The NMR spectrum of a urine sample. A typical NMR spectrum of a urine sample [25]. Peaks due to the metabolite hip-
purate are highlighted.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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lated to the class membership vector. Once a PLS model
has been built the influence of individual features may be
captured with VIP (variable influence on the projection)
measures derived from the PLS coefficients for the opti-
mal set of components [11]. Features may then be ranked
by VIP scores and selected after the choice of an appropri-
ate threshold (usually α ≥ 1). Clearly the chosen threshold
value may greatly affect the set of retrieved features. PLS-
DA is also scale dependent with the choice of scaling fac-
tor again affecting features selected [21]. Unit scaling (1/
SD) can produce loadings that are difficult to interpret
and result in artefacts and up-weighting of spectral noise.
Mean centring alone favours features with higher intensity
and variance. Even Pareto scaling (1/ ) may enhance
the contribution of metabolites present at high concentra-
tions [22]. In this study we have applied this latter method
of scaling to our features as a pre-processing step prior to
PLS-DA.
Random Forest feature selection
Random Forest Classification was first proposed by Brei-
man [23]. This technique is based on growing many clas-
sification trees. A classification tree is an example of a
supervised classification method in which feature values
are used to build a model that enables the classification of
unlabelled samples.
Random Forests may also be used as a basis to gain further
insights into the data. One such extension allows Random
Forest to assign importance values to features in terms of
their influence on the classification accuracy of the forest
and thus has been used to aid feature selection.
The influence of a particular feature on the classification
accuracy of the Random Forest is referred to as its impor-
tance and may be evaluated by randomly permuting the
feature over samples in each tree's 'out-of-bag' test set.
These samples are then reclassified using the Random For-
est. The difference in the number of correct classifications
between the initial 'out-of-bag' data and the permuted
'out-of-bag' data is then divided by the number of trees in
the forest and yields the importance value for that feature.
The advantage of the Random Forest importance measure
in feature selection over univariate screening methods is
that it covers the impact of each feature individually as
well as its multivariate interactions with other features.
For example, Lunetta et al. find that genetic markers rele-
vant in interactions with other markers or environmental
variables can be detected more efficiently by means of
Random Forests than by means of univariate screening
SD
The feature analysis pipeline Figure 2
The feature analysis pipeline. The Metabolomics feature analysis pipeline incorporating MetaFIND as an additional post-
feature selection step.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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methods like Fisher's exact test. As Random Forests are
based on decision trees they also deal well with differently
scaled features [24]. This is quite relevant to metabo-
lomics data where the peaks may vary greatly in height
(intensity).
Post-feature selection analysis
Given the high number of features and the high degree of
feature collinearity in metabolomics data there is always
potential, regardless of the feature selection technique
employed, for the omission of explanatory features. The
presence of noisy features, especially at lower scales
(intensities) also adds to the risk of over-fitting and subse-
quent retrieval of irrelevant features. In the case of PLS-DA
the investigator may use their experience to select an
appropriate scaling technique to minimize the former risk
while maximising the latter. Nevertheless the risk of omit-
ting relevant features, especially of those present at low
intensities, cannot be eliminated. The scale independent
Random Forest based feature selection offers no such
opportunity for feature weighting. As a result there is
added risk of promoting low intensity noisy features
which may demote relevant features that would aid expla-
nation. In both approaches a balance between true and
false positive rates must again be struck during the thresh-
old selection step in which F features are chosen from the
ranked list. Again the high dimensional, multi-collinear
datasets found in metabolomics create further difficulties
at this stage.
To help address these concerns it may be useful to carry
out a second sweep of the dataset for additional features
that may be relevant to the class explanation. One of the
principal functions of MetaFIND is to conduct such a
'post-feature selection' analysis step. The implementation
of this as well as MetaFIND's other functions will now be
discussed in detail.
Implementation
The MetaFIND application contains several components
which support the user in the: (i) reconstruction of the
class discriminating metabolite signatures, (ii) identifica-
tion of additional relevant features omitted from the fea-
ture selection, (iii) identification of correlated metabolites
which may aid the inference of the metabolic correlations
at play in the system under investigation.
The correlation graph
Central to the MetaFIND application is the correlation
graph which provides a medium through which feature
collinearity may be represented and analysed. In this
graph the y-axis represents correlation. As this is derived
from Pearson's correlation, it may render both positive
(above the x-axis) and negative (below the x-axis) correla-
tions. The x-axis represents the binned regions or peak
names assigned to a feature. See Figure 3 for illustration.
The correlation graph enables the user to examine the
intra-feature correlations between a feature retrieved by
feature selection and the rest of features in the dataset.
These features and the dataset are imported into
MetaFIND. As mentioned in the introduction, the fea-
tures, or peaks, which are representative of a particular
class discriminating metabolite should be highly corre-
lated over samples (having the same relative change in
magnitude). Although this correlation may in some cases
be reduced due to the cumulative effect of additional
intensities in a region.
The user selects a reference feature to display from the
imported list via a drop down menu above the correlation
graph. Apart from displaying the list of imported features,
this drop down menu directs the user to features yet to be
examined within the selected set (white font). The cur-
rently displayed set of features (black font) and the previ-
ously viewed features (grey font) are also highlighted in
this list. This function is particularly useful when a large
set (e.g. 100 features) is imported. This function also
means that a user may choose quite a liberal cut-off
threshold during the initial feature selection stage.
Should the current reference feature represent a peak from
a metabolite signature, the user may render this signature
at a certain correlation threshold. Ordinarily the identifi-
cation of this threshold and signature may prove a tedious
pursuit with an investigator having to generate graphs at
numerous correlation thresholds before happening upon
the optimal rendering. However, MetaFIND extends this
correlation graph concept into an interactive application
in which thresholds may be tweaked and assessed in real-
time (via the correlation slider). This allows a rapid retrieval
of the optimal metabolite signature and potentially aids
the identification of class discriminating metabolites.
The current reference feature is projected as a red line in
the correlation graph. Correlated features above the cho-
sen threshold appear as black lines (part of imported fea-
ture list) and green lines (new features not retrieved by
feature selection) of appropriate height (correlation y)
and position (spectral region x). Green lines represent rec-
ommended features and may represent part or all of a rele-
vant metabolite signature overlooked by feature selection.
If the reference feature represents part of a metabolite the
rest of the features within this signature should appear at
an optimal threshold. As the correlation is lowered below
the optimal threshold more peaks will appear. These
peaks may appear above and below the x-axis representing
positive and negative correlations respectively. Correlated
features may appear alone or in groups above the axis andBMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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may represent additional metabolite signatures which are
positively correlated to the reference feature (and the
metabolite it may partially represent). These signatures
may represent additional, correlated metabolites, which
increase and decrease in tandem with the reference feature
(and metabolite) and may help infer metabolic correla-
tions. Should these feature sets appear below the x-axis
they may represent a negatively correlated metabolite sig-
nature. Again these features may be projected as either
black or green lines depending on their presence or
absence from the initial imported list.
The interactive correlation graph also contains an addi-
tional zoom function which is very useful when display-
ing a high number of features (e.g. 5 – 10,000). The user
can then enlarge a region by simply clicking and dragging
the cursor over the area of interest. Having selected the
appropriate resolution the user may then scroll left or
right using the arrow buttons above the correlation graph.
Once a feature of interest is identified it may be further
assessed by plotting its values over all samples. This is
achieved by clicking on the projected feature which dis-
plays the feature plot.
The feature plot
The feature plot facility supports the user in determining
the relevance of a feature of interest by examining how its
values change over samples. In this way feature magnitude
(intensity), class discrimination and outlying samples
may be quickly examined. The MetaFIND application also
allows a feature plot to be retained on the desktop for ref-
erence and comparison with other features. In this way
the user may also directly compare the feature vectors.
This function is useful for determining the features which
are representative of a single metabolite signature. The
feature plot also contains a tool-tip function which allow
MetaFIND screen shot Figure 3
MetaFIND screen shot. The MetaFIND Application. Upon selection of the reference feature from the Drop Down Menu 
(features yet to be examined are displayed in white font) the Correlation Graph displays positively and negatively correlated 
features from the imported list (black). Novel Recommended Features are also displayed (green). Feature values may be exam-
ined globally (Feature Heatmap) and for selected features (Feature Plot). In this example the features most highly correlated (r ≥ 
0.92) to the Reference Feature represent the metabolite hippurate.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
Page 7 of 13
(page number not for citation purposes)
feature identifiers to be displayed. Lastly, the feature plot
also provides the p-value for each feature in the form of
the non-parametric Kruskal-Wallis statistic. Although not
demonstrated here, MetaFIND may be used to analyse fea-
ture significance over multiple sample classes. For simul-
taneous assessment of all currently displayed features the
heatmap function may be also be used.
The heatmap
The heatmap displays a colour representation of the val-
ues of all currently displayed features over all currently
displayed samples. This function provides an alternative
way to rapidly assess many features simultaneously. This
display is also interactive returning feature names and val-
ues for individual samples. In practice the heatmap allows
the user to rapidly assess the class separation and correla-
tion of hundreds of features and direct the user to regions
of interest. The user may then carry out a more detailed
examination of these regions using the correlation graph
and the feature plot functions. The heatmap is activated
by clicking on the heatmap button above the correlation
graph and it appears below the graph on the screen.
The class spectrum
The class spectrum function in MetaFIND allows the user
to display the mean class values for the currently dis-
played features. This class spectrum plot allows the user to
view the mean magnitude of features over a sample class
and aids preliminary identification of peaks. This again
contains a tool-tip interaction and fulfils a role similar to
that of the heatmap in directing the user to general regions
of interest. The class spectrum is activated by clicking on
the class spectrum button above the correlation graph.
Once opened both the heatmap and the class spectrum
displays are tied to the main correlation graph and
dynamically change in response to the currently displayed
features.
Implementations
We used the R statistical computing language for the basic
Random Forest implementation. This utilizes Breiman's
original Fortran code for Random Forest and is also the
most practical implementation available in having suffi-
cient speed to handle the large features sets in Metabo-
lomics Data. PLS-DA was carried out using SIMCA-P+
(Umetrics, Sweden). The MetaFIND feature analysis
application is implemented in Java and utilizes the JFree-
Chart and JCommons packages. MetaFIND and related doc-
umentation are available at http://mlg.ucd.ie/metafind.
Results and discussion
In this section we present an evaluation of the MetaFIND
application using two metabolomics datasets described in
section 3.1. The objective of this evaluation is to establish
if MetaFIND can support the feature selection and subse-
quent metabolite identification processes. We employ
MetaFIND in a post-feature selection capacity supporting
diverse feature selection methods based on PLS-DA and
Random Forests (see section 1.1).
Metabolomics data
Two NMR datasets were used in the evaluation. The first
dataset (Dataset 1) is derived from a previously published
study [25]. This dataset consists of 60 spectral profiles
(derived from urine samples of 21 subjects) over 387
spectral bins in the range 0.5–10 ppm. There are three
classes of dietary intake corresponding to three different
dietary regimes. The second dataset (Dataset 2) is derived
from a NMR analysis of different brain region in rats
[unpublished data]. It consists of 33 spectral profiles over
7901 spectral bins. The data contains 4 classes, pre-frontal
cortex (PFC), hippocampus (H), cerebellum (C) and
brain stem (BS). A sample of this dataset is available to
download with the MataFIND application at http://
mlg.ucd.ie/metafind. For further details, including experi-
mental parameters and conditions, see [25].
MetaFIND evaluation
Post-feature selection analysis using MetaFIND
In PLS-DA based feature selection using VIP scores a cut-
off threshold of 1 was used to select the most important
features. In the case of the Random Forest feature selec-
tion technique the variable importance plot was used to
aid threshold selection, see Figure 4. In the diet dataset a
sharp drop over the first 20 or so features is clearly visible
in feature importance plot. In this diet data the top 20 fea-
tures were selected for further analysis. A similar method
was used to direct the selection of the top 100 features in
the brain tissue dataset. Differing modes of threshold
selection again create further diversity between the two
feature selection methods used in this study. The aim of
the remainder of this section is to evaluate how MetaFIND
performs when used in conjunction with these alternative
feature selection strategies.
Dataset 1: diet study
The features selected by PLS-DA for Dataset 1 were
imported into the MetaFIND application. Features
selected as being discriminating between classes Day 1
and Day 3 were first examined. The metabolite signature
modelling aspect of MetaFIND can be seen in Figure 5(a).
Feature 7.85 (2.98 × 10-6) was selected as the reference fea-
ture and the correlation threshold was gradually lowered
using the correlation slider. The first most highly corre-
lated (r = 0.92) features to appear are those that represent
hippurate (spectral regions 3.96–3.98 ppm, 7.54–7.56
ppm, 7.56–7.58 ppm, 7.84–7.86 ppm). As the correlation
is further lowered the first features to appear below the x-
axis are 3.05 and 4.07 which represent creatinine. Feature
plots were then generated for 7.85 and 3.97 (bottom left)BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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and showed these were present at a higher intensities on
Day 1 compared to Day 3. Features representing creati-
nine (3.05, p = 1.78 × 10-2 and 4.07, p = 1.22 × 10-3) are
present at lower levels on Day 1 than on Day 3. Feature
plots for these features are shown on the bottom right.
The correlation plot suggest that the intensity of the fea-
tures representing each metabolite may be anti-correlated.
Several  recommended  features are also highlighted in
green. In the region 6.5–9.5 ppm, as shown in Figure 5(b),
the feature plot for the recommended feature 9.13 (p =
1.42 × 10-6) is displayed. Further investigation assigned
this to nicotinic acid. This is an example of a feature over-
looked during the initial PLS-DA feature selection that
was representative of a metabolite that shows some class
discrimination (p = 1.42 × 10-6), illustrating the potential
benefit of the feature discovery aspect of MetaFIND. Apart
from using the feature plot, recommended features may
be assessed via the class spectrum, as shown bottom right
in Figure 5(b). This can be used for a preliminary assess-
ment of the feature class separation. The investigator may
then return to the original spectral data for confirmation.
Further features uncovered by MetaFIND are presented in
Table 1 and Figure 6.
Feature importance graph for the diet study (Dataset 1) Figure 4
Feature importance graph for the diet study (Dataset 1). Assessing the trend of importance scores may aid threshold 
selection in Random Forest feature selection. Presented here is the feature importance trend for Dataset 1.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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Dataset 2: brain region study
Feature selection was carried out on Dataset 2 for each
brain region class comparison. Dataset 2 contains many
more features than Dataset 1 and as a result a greater
number of significant features are retrieved by PLS-DA
and Random Forest feature selection methods. PLS-DA
selected 41 features that discriminated between the brain
stem and cerebellum classes, 32 features for the brain
stem and hippocampus classes and 28 for the hippocam-
pus and cerebellum classes. Random Forest feature selec-
tion retrieved 100 discriminating features for each class
comparison.
MetaFIND was then used to carry out post-feature selec-
tion analysis. Figure 7 shows the correlation graph after
the features selected by PLS-DA were imported. The cere-
bellum and hippocampus class comparison was first
examined. The reference feature is 1.326 (red) represents
part of the lactate signature (1.326 ppm & 1.340 ppm).
Lactate is present at higher levels in the cerebellum com-
pared to the hippocampus. As the correlation threshold is
lowered the rest of the lactate signature appears first. This
is followed by the myo-inositol (3.236 ppm) signature
and creatinine signature (3.041 ppm & 3.936 ppm) above
the  x-axis (positively correlated) and the NAG (2.060
ppm) signature and glutamine/glutamate (Gln/Glu) sig-
nature (2.338 ppm & 2.757 ppm) below the x-axis (nega-
tively correlated). Additional discriminating features (11)
were recommended by MetaFIND for this class compari-
son and can be seen in Table 2. All features represent
peaks and separate the classes fully (p-value of 7.78E-4.).
Additional recommended features, recommended after
Random Forest feature selection may also be seen in Table
2. Those marked with an asterisk represent verified peaks
missed by Random Forest feature selection but caught by
MetaFIND post-feature selection analysis.
In Table 3, brain stem vs. cerebellum comparison, 19
additional features were recommended by MetaFIND
after importing features selected by PLS-DA. Most features
separated the classes fully (p-value of 7.78E-4.). Of these
1.894 ppm, 1.909 ppm, 1.938 ppm peaks belong to
GABA. Additional features (26) were also uncovered by
MetaFIND upon importing those retrieved by Random
Forest feature selection. These included features which
represented the lactate, NAA and taurine metabolites
(marked with an asterisk). Similar results can be seen in
Table 4, with MetaFIND recommending additional dis-
Table 1: MetaFIND uncovers additional features from Dataset 1.
PLS-DA Random Forest
Day 1 vs Day 3 Day 3 vs Day 5 Day 1 vs Day 3 Day 3 vs Day 5
FS MF P-value VIP FS MF P-value VIP FS MF P-value Imp.Rank FS MF P-value Imp.Rank
3.97 9.13* 1.42E-4 0.64 3.05 8.55 1.01E-5 0.61 6.97 3.97* 4.53E-4 26 7.85 3.05* 1.78E-2 36
7.85 8.85 9.99E-4 0.75 4.07 8.57 2.52E-4 0.53 3.39 7.57* 4.07E-5 21 3.97 4.07* 1.22E-3 50
7.55 2.45 5.62E-2 0.75 7.15 8.25 1.34E-3 0.35 7.85 4.05* 1.33E-3 30 7.55 3.07* 2.07E-4 22
7.83 6.87 5.06E-3 0.49 7.19 8.15 8.57 4.27E-3 57 7.83 2.17 5.57E-2 141
4.05 8.05 1.78E-2 0.65 3.31 7.55 2.45 5.62E-2 139 7.57 7.75 2.44E-3 30
7.57 8.25 4.09E-4 0.71 7.17 7.65 7.65 6.93 8.59E-4 23
7.65 8.29 7.64E-3 0.68 3.07 6.85 6.97
7.63 3.13 7.63 7.63
3.53 3.97 2.81 8.55
8.55 7.85 7.83 7.67
8.57 7.83 1.97 1.13
3.73 7.55 8.25 8.25
3.53 7.57 9.13 3.39
4.07 7.65 2.83 8.57
3.05 3.71 3.53 3.89
3.75 3.69 7.15 7.11
7.15 7.63 8.83 3.95
8.15 7.13 1.29 3.49





Represented below are the initial features selected by PLS-DA (VIP cut-off ≥ 1) and Random Forest (RF) feature selection techniques, denoted by FS 
for classes Day 1 vs. Day 3 and Day 3 vs. Day 5 in Dataset 1. Also represented in bold are the additional features discovered by MetaFIND, denoted 
by MF. The asterisk signifies those additional features discovered by MetaFIND that were identified as being representative of all or part of a class 
discriminating metabolite. The original VIP scores/RF Importance Rank (Imp. Rank) of the features discovered by MetaFIND are also given.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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criminating peaks for brain stem vs. hippocampus com-
parison, for both PLS-DA and RF feature selection
methods. In Table 4 MetaFIND aids retrieval of part of the
Glu/Gln peak signature which was omitted by the initial
feature selection. The feature plot showing the class sepa-
ration of these peaks is illustrated in Figure 8.
Conclusion
The high dimensionality and multi-collinear nature of
metabolomics data provides a significant challenge for
both feature selection and subsequent metabolite annota-
tion. These issues combined with other factors such as
experimental noise, scaling and threshold selection may
lead to the omission of features relevant to class explana-
tion. To address this risk we have developed the
MetaFIND application to enable the investigator to carry
out an effective 'post-feature selection' correlation analy-
sis. MetaFIND supports the user in metabolite signature
identification, feature discovery and may aid inference of
metabolic relationships by identifying highly correlated
metabolites.
In this study two diverse feature selection methods,
namely PLS-DA and Random Forest, were applied to two
metabolomics datasets. In all cases the MetaFIND applica-
tion aided retrieval of additional class discriminating
peaks, some of which were subsequently found to repre-
sent relevant class discriminating metabolites. Lastly,
MetaFIND supports the investigator in the discovery of
correlated metabolites, this information may then aid in
Analysis of Dataset 1 using MetaFIND Figure 5
Analysis of Dataset 1 using MetaFIND. (a) Analysis of the reference feature 7.85 using MetaFIND. The features repre-
senting the hippurate signature (spectral regions 3.96–3.98 ppm, 7.54–7.56 ppm, 7.56–7.58 ppm, 7.84–7.86 ppm) are the first 
to appear above the x-axis.(b) Region 6.5–9.5 ppm enlarged. Features representing creatinine (spectral regions 3.05 ppm, 4.07 
ppm) appear below the x-axis (anti-correlated). Feature 9.13 (nicotinic acid), omitted by PLS-DA feature selection, was uncov-
ered using MetaFIND.
Features discovered by MetaFIND from Dataset 1 Figure 6
Features discovered by MetaFIND from Dataset 1. Feature plots for selected features that were retrieved by 
MetaFIND analysis, see Table 1 for the full set. The y-axis represents the intensity and the x-axis represents the samples sorted 
by class. Feature 9.13 was subsequently identified as the metabolite nicotinic acid.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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Table 2: MetaFIND uncovers additional features from Dataset 2 
for the Cerebellum vs. Hippocampus class comparison.
Brain Stem vs. Hippocampus
PLS-DA Random Forest
MetaFIND P-Value VIP MetaFIND P-Value Imp.Rank
2.069 7.78E-04 0.82 1.909 7.78E-04 336
2.192 7.78E-04 0.57 2.061* 7.78E-04 174
2.208 7.78E-04 0.69 2.085 7.78E-04 396
2.223 7.78E-04 0.36 2.100 7.78E-04 368
2.732 7.78E-04 0.65 8.573 7.78E-04 408
3.120 7.78E-04 1.01 1.923 1.92E-03 1077
3.873 7.78E-04 0.09 6.154 8.65E-03 1284
3.987 7.78E-04 1.98 3.236* 1.17E-02 1263
3.994 7.78E-04 2.06 1.326* 4.06E-02 1715
6.161 7.78E-04 0.17 1.341* 4.62E-02 2529
8.246 7.78E-04 0.67 1.340* 5.87E-02 1385
1.327* 2.94E-01 2521
Additional class discriminating features recommended by MetaFIND 
after initial PLS-DA (VIP cut-off ≥ 5) and Random Forest (RF) feature 
selection for the Cerebellum vs. Hippocampus class comparison 
(which returned 28 and 100 features respectively). The MetaFIND 
column shows class discriminating features that were retrieved using 
the MetaFIND application. An asterisk signifies that the feature 
represents part of a metabolite with a known assignment. The original 
VIP scores/RF Importance Rank (Imp. Rank) of the features 
discovered by MetaFIND are also given.
Analysis of Dataset 2 using MetaFIND Figure 7
Analysis of Dataset 2 using MetaFIND. Visualization of 
the features that were highly correlated (r = +/- 0.73) to ref-
erence feature 1.326 (red) which represents part of the lac-
tate signature. At this correlation the full lactate signature 
can be seen. The peaks representing myo-inositol (3.236 
ppm), creatinine signature (3.041 ppm & 3.936 ppm) appear 
above the x-axis (positively correlated). Peaks representing 
NAG (2.060 ppm) and Gln/Glu (2.338 ppm & 2.757 ppm) 
appear below the x-axis (negatively correlated).
Table 3: MetaFIND uncovers additional features from Dataset 2 
for the Brain Stem vs. Cerebellum class comparison.
Brain Stem vs. Hippocampus
PLS-DA Random Forest
MetaFIND P-Value VIP MetaFIND P-Value Imp.Rank
2.069 7.78E-04 0.75 1.338* 7.78E-04 365
2.085 7.78E-04 0.72 2.039 7.78E-04 156
2.207 7.78E-04 1.09 2.069 7.78E-04 786
2.540 7.78E-04 0.10 2.085 7.78E-04 330
2.765 7.78E-04 0.39 2.540 7.78E-04 117
2.794 7.78E-04 0.52 3.236* 7.78E-04 199
3.908 7.78E-04 0.50 3.237* 7.78E-04 393
6.079 7.78E-04 0.15 3.307 7.78E-04 1458
6.091 7.78E-04 0.15 3.770* 7.78E-04 105
6.161 7.78E-04 0.13 3.771* 7.78E-04 767
8.425 1.63E-03 0.02 3.935* 7.78E-04 398
2.801 3.28E-03 0.54 6.079 7.78E-04 112
3.686 3.28E-03 1.06 3.235* 1.13E-03 684
6.113 3.28E-03 0.34 3.934* 1.63E-03 896
8.247 4.57E-03 1.00 8.425 1.63E-03 734
1.894* 6.32E-03 0.17 3.681 3.28E-03 854
1.909* 1.17E-02 0.64 6.113 3.28E-03 698




Additional class discriminating features retrieved using MetaFIND 
after initial PLS-DA, VIP cut-off ≥ 6, and Random Forest (RF) feature 
selection for the Brain Stem vs. Cerebellum class comparison (which 
returned 41 and 100 features respectively). The MetaFIND column 
shows class discriminating features that were retrieved using the 
MetaFIND application. An asterisk signifies that the feature 
represents part of a metabolite with a known assignment. The original 
VIP scores/RF Importance Rank (Imp. Rank) of the features 
discovered by MetaFIND are also given.BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
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Table 4: MetaFIND uncovers additional features from Dataset 2 for the Brain Stem vs. Hippocampus class comparison.
Brain Stem vs. Hippocampus
PLS-DA Random Forest
MetaFIND P-Value VIP MetaFIND P-Value Imp.Rank
2.039 7.78E-04 1.52 1.325* 7.78E-04 240
2.069 7.78E-04 2.17 1.339* 7.78E-04 180
2.086 7.78E-04 1.89 1.341* 7.78E-04 1689
2.118 7.78E-04 2.65 1.480 7.78E-04 1033
2.141* 7.78E-04 3.51 1.494 7.78E-04 1659
2.190 7.78E-04 1.78 2.060* 7.78E-04 404
2.207 7.78E-04 2.69 3.218 7.78E-04 591
2.450* 7.78E-04 3.07 3.275* 7.78E-04 933
2.467* 7.78E-04 2.92 3.276* 7.78E-04 109
2.559 7.78E-04 1.40 3.277* 7.78E-04 381
2.732 7.78E-04 1.68 3.278* 7.78E-04 102
2.755 7.78E-04 1.42 3.289* 7.78E-04 1632
3.630 7.78E-04 0.89 3.796 7.78E-04 630
3.646 7.78E-04 3.89 5.940 7.78E-04 482
3.682 7.78E-04 3.50 5.952 7.78E-04 111
3.855 7.78E-04 1.09 6.045 7.78E-04 292
3.873 7.78E-04 0.43 6.079 7.78E-04 214
3.892 7.78E-04 1.18 8.268 7.78E-04 1031
3.994 7.78E-04 2.44 6.034 1.13E-03 1083







Additional class discriminating features recommended by MetaFIND after initial PLS-DA, VIP cut-off ≥ 5, and Random Forest (RF) feature selection 
for the Brain Stem vs. Hippocampus class comparison (which returned 32 and 100 features respectively). The MetaFIND column shows class 
discriminating features that were retrieved using the MetaFIND application. An asterisk signifies that the feature represents part of a metabolite 
with a known assignment. The original VIP scores/RF Importance Rank (Imp. Rank) of the features discovered by MetaFIND are also given.
Features discovered by MetaFIND from Dataset 2 Figure 8
Features discovered by MetaFIND from Dataset 2. Feature plots for part of the Glu/Gln signature that was retrieved by 
MetaFIND analysis of the PLS-DA features in selected for the Brain Stem vs Hippocampus class comparison.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2008, 9:470 http://www.biomedcentral.com/1471-2105/9/470
Page 13 of 13
(page number not for citation purposes)
the construction of networks. This study has illustrated
that the performance of data-driven feature selection
methods may be augmented by additional user-driven
input as supported by the MetaFIND application.
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